4
1
:
3
4
:
3
1
5
2
0
2MetformininCancer
r
p
A
1
1TreatmentandPrevention
,
i
r
F
:
n
ODanielR.Morales1andAndrewD.Morris2
6
2
212
6.PopulationHealthSciencesDivision,MedicalResearchInstitute,andSchoolofMedicine,
2UniversityofDundee,Dundee,UnitedKingdom;email:d.r.z.morales@dundee.ac.uk,
1
5.a.d.morris@dundee.ac.uk
3
1
.
3
2
1
:
P
I
)
9
9
7
5
0
5
-
r
a
(
y
t
i
s
r
e
v
i
n
U
l
a
r
u
t
l
u
c
i
r
g
A
g
n
o
d
n
a
h
S
g.Annu.Rev.Med.2015.66:17–29Keywords
r
o
s.FirstpublishedonlineasaReviewinAdvanceondiabetes,oncology,epidemiology,clinicaltrials
w
eNovember6,2014
i
v
eAbstract
rTheAnnualReviewofMedicineisonlineat
l
a
u
nPatientswithdiabetesmellitusareatincreasedriskofcancerdevelopment.
n
aThisarticle’sdoi:
w.10.1146/annurev-med-062613-093128Metforminisawell-established,effectiveagentforthemanagementoftype2
wdiabetesmellitus.Epidemiologicalstudieshaveidenti?edanassociationbe-
w
c
mCopyright2015byAnnualReviews.tweenmetforminuseandabene?ci